Virscio is a preclinical CRO providing predictive preclinical research models and services in nonhuman primates to accelerate therapeutic candidate evaluation and reduce the risk of clinical failure. Virscio engages with leading pharmaceutical, biotechnology and academic sponsors around the world to design and execute a wide range of preclinical safety studies, from pilot de-risking studies through IND-enabling GLP studies.